Abstract
Radiotherapy represents the most effective non-surgical modality in cancer treatment. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression, and are involved in many biological processes and diseases. To identify miRNAs that influence the radiation response, we performed miRNA array analysis using MCF7 cells at 2, 8, and 24 h post irradiation. We demonstrated that miR-770-5p is a novel radiation-inducible miRNA. When miR-770-5p was overexpressed, relative cell number was reduced due to increased apoptosis in MCF7 and A549 cells. Transcriptomic and bioinformatic analyses revealed that PDZ-binding kinase (PBK) might be a possible target of miR-770-5p for regulation of radiosensitivity. PBK regulation mediated by direct targeting of miR-770-5p was demonstrated using luciferase reporter assays along with wild-type and mutant PBK-3′untranslated region constructs. Radiation sensitivity increased and decreased in miR-770-5p- and anti-miR-770-5p-transfected cells, respectively. Consistent with this result, transfection of short interfering RNA against PBK inhibited cell proliferation, while ectopic expression of PBK restored cell survival from miR-770-5p-induced cell death. In addition, miR-770-5p suppressed tumor growth, and miR-770-5p and PBK levels were inversely correlated in xenograft model mice. Altogether, these data demonstrated that miR-770-5p might be a useful therapeutic target miRNA that sensitizes tumors to radiation via negative regulation of PBK.
Similar content being viewed by others
Main
Radiation therapy is one of the major treatment regimens for cancer patients. Approximately 50% of all cancer patients receive radiotherapy either alone or in combination with other treatment modalities such as surgery or chemotherapy.1 Ionizing radiation (IR) primarily induces damage to many cellular components, including DNA, protein, lipid, and other macromolecules by either direct or indirect generation of reactive oxygen species.2 Radiation-induced DNA damage initiates the DNA damage response (DDR), resulting in activation of multiple signaling checkpoint molecules such as ataxia telangiectasia mutated (ATM), ataxia telangiectasia and Rad3-related (ATR), checkpoint kinase 1 (CHK1), CHK2, and p53. The DDR coordinates repair and cell cycle progression, resulting in determination of cell fate between death and survival.3, 4, 5 Tumor suppressor p53, which is a key regulator in the DDR after IR exposure, undergoes post-translational modification to transcriptionally activate target genes such as Puma, Noxa, Gadd45, and p21.6, 7, 8 However, dysregulation of DDR and other self-repair mechanisms confer resistance to IR, thereby affecting the final outcome of radiation therapy in various cancers.2, 9 Therefore, recent strategies to improve the efficacy of radiation therapy have been actively developed by either antagonizing radiation-induced cellular defense mechanisms or reinforcing radiation-induced antiproliferative potential.
MicroRNAs (miRNAs) are small non-coding RNAs about ∼22 nucleotides in size that function as epigenetic controllers of cellular gene expression.10 The interaction between miRNAs and their target mRNAs through complementary base pairing exerts translational repression and mRNA degradation.11, 12 MiRNAs play important roles in various biological processes such as development, differentiation, cell proliferation, and cell death. Emerging roles of the miRNA signaling network in response to IR have been elucidated.2, 9, 13 For example, the p53-regulated miRNA miR-34a is one of the most important tumor-suppressing miRNA in cancer. MiR-34a sensitizes tumors to IR by targeting RAD51, a central regulator of DNA repair.14 The N-Myc-regulated miR-421 targets the 3′-untranslated region (3′UTR) of ATM mRNA and increases radiosensitivity.15 Elevation of miR-185 sensitizes cancer cells to radiation by targeting ATM and ATR.16 It was previously shown that miR-182 targets BRCA1 to impact homologous recombination-mediated DNA repair and increase cellular radiosensitivity.17 Currently, there is an increasing interest in defining functional miRNAs involving in the tumor radiation response to increase radiosensitivity.
In this study, we found that miR-770-5p is responsive to radiation in MCF7 breast carcinoma cells through miRNA microarray analysis. Specifically, miR-770-5p overexpression increases apoptosis via direct targeting of PDZ-binding kinase (PBK), and finally sensitizes radiation response both in vitro and in vivo. From our results, we propose that miR-770-5p as a potential miRNA for modulating the radiation response as well as a possible predictive biomarker.
Results
MiR-770-5p is an IR-inducible suppressor of cancer cell survival
To identify novel IR-responsive miRNAs, we irradiated MCF7 human breast carcinoma cells with 6 Gy of IR. Total RNAs from irradiated cells were isolated at each time point (0, 2, 8, and 24 h), and analyzed miRNA expression changes by using of miRNA microarray analysis. IR-responsive miRNA profiles were normalized and ranked according to fold changes. Heat maps of the top 20 up and downregulated miRNAs in IR-exposed MCF7 cells are shown in Figures 1a and b. The extended data sets of 229 IR-responsive miRNAs are shown in Supplementary Figure S1. Among them, miR-770-5p, miR-1287, and miR-371-5p exhibited evident induction at every time point post irradiation (2, 8, and 24 h) (Figure 1a). We assessed level changes of miR-770-5p, miR-1287, and miR-371-5p at 2, 8, and 24 h post irradiation by qRT-PCR in MCF7 cells (Figure 1c). Since there is no report regarding the cellular function of miR-770-5p, which was evidently induced by IR exposure, we decided to explore the roles of miR-770-5p and its target in the radiation response. First, we transfected miR-770-5p mimic into MCF7 cells, and examined relative cell number and clonogenicity. Relative cell numbers in miR-770-5p-transfected cells evidently decreased compared to those in miR-control (Con)-transfected cells (Figure 2a). MiR-770-5p-transfected MCF7 cells showed poor clonogenicity (Figure 2c). When we examined the transfection effect of miR-770-5p in A549 human lung adenocarcinoma cells, relative cell numbers and clonogenicity also evidently decreased compared to those in miR-Con-transfected cells (Figures 2a and c). Increased levels of miR-770-5p were confirmed with qRT-PCR at 3 days after transfection in MCF7 and A549 cells (Figure 2b).
Ectopic expression of miR-770-5p per se induces apoptosis
Since we observed profound decreases in relative cell number, and clonogenicity in miR-770-5p-transfected MCF7 and A549 cells, we examined whether or not miR-770-5p could affect cell death. Trypan Blue exclusion assay showed that ectopic expression of miR-770-5p induced cell death in both MCF7 and A549 cells compared to that in miR-Con-transfected cells (Figure 3a). We detected an increase in PARP cleavage, a general marker of apoptosis, in a dose-dependent manner of miR-770-5p in both MCF7 and A549 cells at 72 h after transfection (Figure 3b). MiR-770-5p levels were increased in dose-dependent manner in miR-770-5p-transfected MCF7 and A549 cells (Figure 3c).
PBK is a direct target of miR-770-5p
To identify potential targets of miR-770-5p in miR-770-5p-mediated apoptosis, we analyzed our previous expression array data reflecting changes in global mRNA expression profiles upon IR exposure.18 We obtained 225 IR-repressed genes showing fold changes of <−1.36 (log2) from the expression array analysis (Figure 4a and Supplementary Table S1). We also used miRSVR score19 to predict potential miR-770-5p targets based on the microRNA.org website (www.microrna.org). The 288 candidate targets were selected based on a miRSVR score threshold of <−0.75 (Figure 4a and Supplementary Table S2). From the IR-responsive expression profile and bioinformatics analyses, we finally identified PBK as a strong candidate since it was both highly repressed by IR and shown to contain a target sequence for miR-770-5p in its 3′UTR. To verify whether or not miR-770-5p regulates PBK expression, we evaluated changes in PBK level after transfection of miR-770-5p. After confirmation of increased miR-770-5p levels, we examined PBK mRNA and protein levels in miR-770-5p-transfected cells (Figures 4b and c). MiR-770-5p evidently reduced the PBK mRNA level (Figure 4b, right). MiR-770-5p also reduced the level of PBK protein, and PBK protein level was closely correlated with PARP cleavage (Figure 4c). We also examined PBK level and PARP cleavage in miR-770-5p-transfected HCT116 human colon carcinoma cells (Supplementary Figure S2). Levels of PBK mRNA and protein were evidently decreased and PARP cleavage was observed in miR-770-5p-transfected HCT116 cells (Supplementary Figure S2). PBK harbors a miR-770-5p seed-matched sequence in its 3′UTR, as illustrated in Figure 4d. We next generated reporters containing the firefly luciferase gene followed by either wild-type or mutated PBK-3′UTR in the putative miR-770-5p-binding site (PBK-3′UTR-Wt or PBK-3′UTR-Mut) (Figure 4d). Each firefly luciferase (FL) construct was co-transfected with internal control Renilla luciferase (RL) in the presence or absence of miR-770-5p, after which FL activity was measured and normalized based on RL activity. PBK-3′UTR-Wt reporter activity was reduced compared to the reporter control, whereas PBK-3′UTR-Mut reporter activity was not significantly altered in miR-770-5p-transfected cells (Figure 4e). These data demonstrate that miR-770-5p negatively regulates PBK expression through direct binding to its 3′UTR.
MiR-770-5p sensitizes tumor cells to radiation
To examine the physiological relationship between miR-770-5p and PBK in response to IR, we irradiated anti-miR-Con- and anti-miR-770-5p-transfected MCF7 cells and then examined level changes in PBK expression. IR treatment drastically reduced the amount of PBK protein in anti-miR-Con-transfected cells (Figure 5a). In contrast, anti-770-5p-transfected cells showed restored expression levels of PBK post irradiation (Figure 5a), suggesting that miR-770-5p is a key factor in the regulation of PBK expression upon IR exposure. Next, MCF7 cells were transfected with either miR-770-5p or anti-miR-770-5p, followed by IR exposure at the indicated doses, as shown in Figures 5b and c. Whereas miR-770-5p further reduced clonogenic ability, anti-miR-770-5p increased clonogenic ability post irradiation (Figures 5b and c). These data demonstrate that miR-770-5p plays a critical role in enhancing radiosensitivity via PBK regulation in tumor cells. Effects of miR-770-5p and anti-miR-770-5p transfection on intracellular miR-770-5p levels were validated in non-irradiated and irradiated MCF7 cells (Figures 5a–c). Our findings suggest that IR-induced miR-770-5p potentiates IR sensitivity by promoting apoptotic cell death.
Reconstitution of PBK rescues tumor cells from miR-770-5p-induced cell death
We also examined the effect of PBK knockdown using short interfering RNA on MCF7 cell survival. PBK depletion suppressed clonogenicity and reduced relative cell numbers (Figure 6a). Because of the existence of multiple targets for a single miRNA,11 we examined whether or not miR-770-5p exerts a proapoptotic effect through targeting of PBK. Flag-tagged PBK lacking its 3′UTR containing the target region of miR-770-5p (p3 × Flag-PBK-ORF) was generated and co-transfected with miR-770-5p into MCF7 cells. When we performed immunoblot analysis, miR-770-5p evidently reduced the level of endogenous PBK, but had no effect on PBK expression from p3 × Flag-PBK-ORF (Figure 6b, bottom). MiR-770-5p-induced cell death was evidently reduced by ectopic expression of p3 × Flag-PBK-ORF (Figure 6b, top). These results indicate that miR-770-5p potentiates cell viability through direct targeting of PBK. Taken together, our data suggest that IR-responsive miR-770-5p plays a role in induction of apoptosis via regulation of PBK expression. Thus, further increasing the miR-770-5p level in IR-exposed cells can likewise increase the radiosensitivity of tumor cells to IR.
MiR-770-5p retards tumor growth in a xenograft tumor mouse model through PBK targeting
To explore the biological significance of our in vitro observations, we examined the role of miR-770-5p in a xenograft tumor mouse model. We found that the growth rate of xenografted tumors was significantly retarded in mice injected subcutaneously with miR-770-5p (100 nM)-transfected cells compared to mice injected with miR-Con-transfected cells (Figure 7a). We tracked the extent of PBK expression in tumor tissues injected with miR-770-5p- and miR-Con-transfected cells. Western blot analysis demonstrated that PBK expression was attenuated in tumor tissues bearing miR-770-5p (Figure 7b). To confirm that reduction of PBK expression was due to the effects of miR-770-5p transfection in vivo, we analyzed miR-770-5p and PBK mRNA levels using quantitative reverse transcription-PCR (qRT-PCR) in tumor tissues (Figure 7c). Correlation between miR-770-5p and PBK mRNA levels in tumor tissues was normalized and assessed using the Pearson correlation coefficient, and the R-value indicated a negative correlation between miR-770-5p and PBK expression (R=−0.656). Plot of the miR-770-5p and PBK mRNA levels from each tumor tissue showed distinct clustering (Figure 7d). These data indicate that miR-770-5p suppresses PBK expression, resulting in tumor growth retardation.
Next, since we wanted to know whether miR-770-5p could sensitize tumors to IR in vivo, we developed a xenograft tumor mouse model and allowed to form tumor. And then, we injected 10 nM of miR-770-5p to the whole tumor mass and locally exposed 2 Gy of IR to xenograft tumor 1 day after injection. Combination treatment group (miR-770-5p+IR) significantly suppressed tumor growth compared to other groups of mice (miR-Con, miR-770-5p, and miR-Con+IR) (Figure 8a). In combination treatment group, we observed significant decrease of PBK mRNA and attenuated expression of PBK protein (Figures 8b and c). Negative correlation between miR-770-5p and PBK (R=−0.356) was appeared as shown in Figure 8d. Since we applied low concentration of miR-770-5p (10 nM) and low dose of IR (2 Gy) once to evaluate the combination effect of mIR-770-5p and IR, no marked change of either miR-770-5p or PBK expression was observed in either IR- or miR-770-5p-treated groups (Figures 8b and c). These data indicate that miR-770-5p sensitized tumors to radiotherapy through the suppression of PBK expression. Collectively, our results suggest that miR-770-5p could be a potential target for the radiotherapy.
Discussion
Great technological progress in radiation therapy has been achieved over the last 20 years, and the ability to cure a wide range of malignancies has been attained. Research in radiation biology is currently focused on increased radiotherapy efficacy. To approach this goal, we have to better understand the cellular response to IR exposure. Each cell determines whether the cell will die, repair the damage, or proceed through cellular division despite the damage after a critical period from radiation exposure.20 On the molecular level, radiation-induced damage initiates a complex signaling cascade in cells, resulting in a variety of responses that include cell cycle arrest, induction of stress-response genes, DNA repair, and apoptosis.21 IR damage activates a number of stress-response-signaling pathways that contribute to lethality, and many of these may be independent of DNA damage.20, 21 Radiation can also up or downregulate miRNA expression, and such alteration of miRNA expression profiles could affect the final outcome of radiation therapy.
MiRNAs are found in most eukaryotes and are involved in many important cellular responses.22 It has recently been shown that expression levels of miRNAs vary significantly after IR exposure.2, 9, 13 The IR-induced DDR modulates miRNA expression and biogenesis. In addition, Mao et al.23 and Marta et al.21 very recently reviewed IR-responsive miRNAs and their targets in various cell lines. Regulation of miRNAs was shown to influence cellular sensitivity to radiation, primarily through modulation of molecules involved in the DDR such as ATM, ATR, RAD51, and DNA-PK.2, 9, 13 In particular, miR-421 suppresses ATM expression and increases sensitivity to IR.15 MiR-214 is upregulated in radio-resistant non-small cell lung cancer (NSCLC) cells relative to their radiosensitive counterparts.24 Overexpression of miR-214 in radiosensitive NSCLC cells protects against RT-induced apoptosis via downregulation of p38 kinase. Elevation of miR-185, which is downregulated in response to IR sensitizes renal cell carcinoma cells to IR both in vitro and in vivo by targeting ATR kinase.16 The p53-responsive miRNA miR-34a binds to the 3′UTR of RAD51 and inhibits double-strand break repair in NSCLC cells.14
Until now, three papers regarding miR-770-5p have been reported. Specifically, miR-770-5p was shown to be highly expressed in type 2 diabetes mellitus patients,24 whereas miR-770-5p was found to be downregulated in a rat model of temporal lobe epilepsy compared with the control group.22 Zhao et al.25 reported very recently that miR-770-5p expression served as a prognostic biomarker and overexpression of miR-770-5p reduced survival in cisplatin-treated ovarian cancer cells. They showed that miR-770-5p inhibits cisplatin chemoresistance by targeting ERCC2 in vivo and in vitro in human ovarian cancer. In this study, we identified miR-770-5p as an upregulated miRNA in response to IR. Overexpression of miR-770-5p induced apoptosis, and elevation of miR-770-5p sensitized MCF7 breast carcinoma and A549 lung carcinomas to IR through direct targeting of PBK. Ectopic expression of miR-770-5p in tumor tissue exhibited retarded tumor growth in xenograft model mice. We also demonstrated an inverse correlation between miR-770-5p and PBK both in vitro and in vivo. PBK was identified as an upregulated serine–threonine kinase in Burkitt’s lymphoma cell lines.26, 27, 28 PBK was further shown to be upregulated in rapidly proliferating cells as well as a variety of tumor.29, 30, 31 PBK was shown to promote transformation,28 and knockdown of PBK reduced tumorigenic and metastatic properties both in vivo and in vitro.32, 33, 34 Many studies have also strongly demonstrated that PBK inhibition might be beneficial for tumor regression and a good prognosis.35, 36, 37 Consistent with the role of PBK in previous studies, this study suggests that PBK could be a useful therapeutic target for a sensitized IR response and could be achieved through ectopic expression of miR-770-5p. We searched deep sequencing online data to demonstrate correlation between miR-770-5p and PBK in human tissues (miRGator.kobic.re.kr). As based on small RNA-seq from ENCODE Database, we identified strong negative correlation between miR-770-5p and PBK (correlation coefficient (r) value was −0.67). In analysis from TCGA-breast invasive carcinoma Database, r-value between miR-770-5p and PBK was −0.31. We believe that these analysis data further support our conclusion.
The field of miRNA study is currently one of the fastest growing research fields. The involvement of miRNAs in important biological processes and diseases underlines their importance. Specifically, the diagnostic and prognostic value of miRNAs in cancer cannot be overemphasized. We suggest that miR-770-5p is a promising agent to improve the efficacy of cancer radiotherapy. In general, many miRNAs modulate radiosensitivity by targeting the DDR. However, we showed that miR-770-5p renders radiosensitivity through blockade of the PBK signaling pathway. Despite numerous studies regarding the oncogenic potential of PBK, we report here for the first time that miR-770-5p can directly target PBK in the radiation response. Alteration of miR-770-5p expression upon IR can be used not only as a promising method for improving the efficacy of cancer radiotherapy, but also as a biomarker for IR exposure.
Materials and methods
Cell culture
MCF7 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; WelGENE, Daegu, Korea), A549 cells were cultured in RPMI 1640 (WelGENE), and HCT116 cells were cultured in McCoy’s 5A medium (WelGENE) at 37 °C in a 5% CO2 incubator. Cell culture medium was supplemented with 10% fetal bovine serum (Lonza, Basel, Switzerland), 1% penicillin, and streptomycin solution (WelGENE).
Plasmid construction
Plasmid expressing hsa-miR-770-5p was generated using genomic DNA from A549 cell lines as a template, as well as 5′-atgcctcgagAAAGTGGGGTGCTCAGGAAT-3′ and 5′-atgcgcggccgcGGAGAAGCTTCAGCAGGTGT-3′ as primers. Amplified PCR products were inserted between the XhoI and NotI sites of pLCE vector.37 To investigate the direct effect of miR-770-5p on the 3′ UTR of PBK (PBK-3′UTR), we amplified the 3′UTR of PBK from A549 cDNA libraries by PCR using 5′-atgcctcgagTGATCATCTCAGCTGAAGTG-3′ and 5′-atgcgcggccgcTTGTACTGTACAAAGTGCTA-3′ primer pairs, and the resulting products were ligated into the 3′UTR of the firefly luciferase (Fluc) reporter gene. The Fluc-PBK-3′UTR reporter plasmid (pFluc-PBK-3′UTR-Wt) was sequenced. pFluc-PBK-3′UTR-Mut harboring miR-770-5p seed region mutations (GTACTGG to GTAGTGC) was generated from pFluc-PBK-3′UTR-WT as a template with 5′-GCACTTFFAATTGTAGTGCGTTTTCTGTAAAG-3′ and 5′-CTTTACAGAAAACGCACTACAATTCCAAGTGC-3′ using a QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA).
Irradiation
Cells were irradiated to γ-ray using a 137Cs γ-ray source (Atomic Energy of Canada Ltd, Mississauga, Ontario, Canada) at a dose rate of 3.2 Gy per min. Cells were exposed using the indicated single irradiation dose (6 Gy) and then collected at the indicated times in each experiment.
MiRNA array analysis
MiRNA-enriched total RNA from MCF7 cells exposed to 6 Gy of IR was extracted using TRI reagent (Molecular Research Center, Cincinnati, OH, USA) following the manufacturer’s protocol. Samples of miRNA-enriched total RNA were labeled and hybridized using a miRNA Labeling Reagent and Hybridization Kit (Agilent, Santa Clara, CA, USA) according to the manufacturer’s protocol. After hybridization, the miRNA microarray was washed in GE Wash Buffer 1 (Agilent) and GE Wash Buffer 2 (Agilent) for 5 min in turn. The slides were then scanned with Agilent Microarray Scanner (Agilent). The microarray images were analyzed with Feature Extraction Software (Agilent). MiRNAs were considered as significantly differentially expressed if their ratios were >2.0 or <0.5.
qRT-PCR analysis
Total RNA was isolated and subjected to reverse transcription using RevertAid H Minus Reverse Transcriptase (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s recommendations. MiRNAs were isolated and subjected to reverse transcription using a GenoExplorer miRNA First-Strand cDNA Core Kit (GenoSensor Corporation, Tempe, AZ, USA) according to the manufacturer’s instructions. The qRT-PCR was performed using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) on Chromo4 Real-Time PCR Detection System (Bio-Rad) with mRNA-specific primers: for PBK, 5′-TCTCATTCTCCTTGGGCTGT-3′ (sense) and 5′-AAAGGATCTTGGCTGGCTTT-3′ (antisense); and for actin, 5′-CAAGAGATGGCCACGGCT-3′ (sense) and 5′-TCCTTCTGCATCCTGTCGGC-3′ (antisense). The miRNA-specific primers were purchased from GenoSensor Corp. The relative fold change of RNA expression values was normalized to that of an internal control (5S rRNA or actin mRNA).
Immunoblot analysis
Cells lysates were prepared in RIPA lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS) containing protease inhibitor (Roche, Indianapolis, IN, USA). Before electrophoresis, lysates were mixed with 2 × Laemmli sample buffer and boiled. The protein concentration was determined using the Bio-Rad Protein Assay kit according to manufacturer’s protocol (Bio-Rad). Equal amounts of protein (30 μg) were fractionated by SDS-PAGE and then transferred to a nitrocellulose membrane. The nitrocellulose membrane was blocked with 5% non-fat milk and incubated with primary antibodies at 4 °C overnight. Then, blots were incubated with horseradish peroxidase-conjugated goat anti-mouse and goat anti-rabbit antibodies. Protein detection was conducted with ECL reagents (Thermo Scientific, Waltham, MA, USA).
Dual luciferase reporter assay
Luciferase reporter assay was performed as previously described.33 RL reporter control plasmid (pRluc) was co-transfected into 293 T cells with pFluc, pFluc-PBK-3′UTR-Wt, or pFluc-PBK-3′UTR-Mut, together with miR-770-5p-expressing plasmid using FuGENE6 (Promega, Madison, WI, USA). FL and RL activities were evaluated by using the Dual Luciferase Reporter Assay System (Promega) and VICTOR X Light plate reader (PerkinElmer), after which FL activity was normalized by RL activity.
Transfection
Cells were transfected with miR-770-5p mimic or mimic control (GenoExplorer) using Lipofectamine RNAiMAX (Invitrogen, Karlsruhe, Germany). In the same way, cells were transfected with either anti-miR-770-5p or anti-miR control. Transfection of plasmids was carried out using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s instructions.
Cell growth rate and colony-forming assay
Cell growth rate was determined by counting viable cells after staining with Trypan Blue (0.4%; GIBCO, Grand Island, NY, USA). Viable (unstained) and dead (stained) cells were counted by hemocytometer microscopy. Clonogenicity was examined using colony-forming assay. Approximately 1 × 104 cells were seeded on 60 mm plates and cultured for 7 days. Colonies were stained with Diff-Quick (Sysmex, Kobe, Japan).
Xenograft mice model experiment
For xenograft mice model experiment to examine effect of miR-770-5p on tumor growth, HCT116 cells (5 × 106) transfected with 100 nM of miR-Con or miR-770-5p were injected subcutaneously into the lateral hind leg of 6-week-old immunodeficient BALB/c female nude mice (nu/nu; Orient Bio Inc., Seongnam, Korea) for each group (n=5). Tumor growth was monitored periodically for 16 days. For xenograft mice model experiment to examine combination effect of miR-770-5p and IR on tumor growth, HCT116 cells (5 × 106) were injected subcutaneously into the lateral hind leg of 6-week-old immunodeficient BALB/c female nude mice (nu/nu; Orient Bio Inc.) for each group (n=9). When the tumor reached an average volume of ~200 mm3, 10 nM of miR-Con or miR-770-5p with AteloGenes Local Use (KOKEN, Tokyo, Japan) was injected to wrap up the whole tumor mass. Xenografted tumors were locally exposed to IR of 2 Gy 1 day later. Local regional irradiation of xenografted tumor was performed under anesthesia using X-RAD 320 irradiator (Precision X-ray Ltd, North Branford, CT, USA). Tumor growth was monitored periodically for 12 days. Average tumor volume (V) was determined as (L × W2)/2; measurements of tumor length (L) and width (W) were taken with a caliper. All animal studies were conducted with the approval of the Institutional Animal Care and Use Committee of the Korea Institute Radiological and Medical Sciences (approval nos KIRAMS 2014-0017 and KIRAMS 2016-0064).
Statistical analysis
Differences between the experimental groups were calculated using Student’s two-tailed t-test. P-values of <0.05 were considered to be statistically significant. Correlation between PBK mRNA and miR-770-5p levels in tumors was assessed using Pearson’s correlation coefficient analysis.
References
Begg AC, Stewart FA, Vens C . Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 2011; 11: 239–253.
Czochor JR, Glazer PM . microRNAs in cancer cell response to ionizing radiation. Antioxid Redox Signal 2014; 21: 293–312.
Zhou BB, Elledge SJ . The DNA damage response: putting checkpoints in perspective. Nature 2000; 408: 433–439.
Cimprich KA, Cortez D . ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 2008; 9: 616–627.
Reinhardt HC, Yaffe MB . Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 2009; 21: 245–255.
He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130–1134.
Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003; 4: 321–328.
Fei P, El-Deiry WS . P53 and radiation responses. Oncogene 2003; 22: 5774–5783.
Gandellini P, Rancati T, Valdagni R, Zaffaroni N . miRNAs in tumor radiation response: bystanders or participants? Trends Mol Med 2014; 20: 529–539.
Srikantan S, Marasa BS, Becker KG, Gorospe M, Abdelmohsen K . Paradoxical microRNAs: individual gene repressors, global translation enhancers. Cell Cycle 2011; 10: 751–759.
Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.
Huntzinger E, Izaurralde E . Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011; 12: 99–110.
Metheetrairut C, Slack FJ . MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev 2013; 23: 12–19.
Cortez MA, Valdecanas D, Niknam S, Peltier HJ, Diao L, Giri U et al. In vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulation. Mol Ther Nucleic Acids 2015; 4: e270.
Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA . ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA 2010; 107: 1506–1511.
Wang J, He J, Su F, Ding N, Hu W, Yao B et al. Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition. Cell Death Dis 2013; 4: e699.
Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, Muschel RJ et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 2011; 41: 210–220.
Kim BC, Han NK, Byun HO, Kim SS, Ahn EK, Chu IS et al. Time-dependently expressed markers and the characterization for premature senescence induced by ionizing radiation in MCF7. Oncol Rep 2010; 24: 395–403.
Betel D, Koppal A, Agius P, Sander C, Leslie C . Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 2010; 11: R90.
Spitz DR, Azzam EI, Li JJ, Gius D . Metabolic oxidation-reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 2004; 23: 311–322.
Marta GN, Garicochea B, Carvalho AL, Real JM, Kowalski LP . MicroRNAs, cancer and ionizing radiation: where are we? Rev Assoc Med Bras 2015; 61: 275–281.
Jovanovic M, Hengartner MO . miRNAs and apoptosis: RNAs to die for. Oncogene 2006; 25: 6176–6187.
Mao A, Liu Y, Zhang H, Di C, Sun C . microRNA expression and biogenesis in cellular response to ionizing radiation. DNA Cell Biol 2014; 33: 667–679.
Salim H, Akbar NS, Zong D, Vaculova AH, Lewensohn R, Moshfegh A et al. miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Br J Cancer 2012; 107: 1361–1373.
Zhao H, Yu X, Ding Y, Zhao J, Wang G, Wu X et al. MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2. Oncotarget 2016; 7: 53254–53268.
Gaudet S, Branton D, Lue RA . Characterization of PDZ-binding kinase, a mitotic kinase. Proc Natl Acad Sci USA 2000; 97: 5167–5172.
Abe Y, Matsumoto S, Kito K, Ueda N . Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J Biol Chem 2000; 275: 21525–21531.
Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D et al. PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells. Blood Cells Mol Dis 2001; 27: 825–829.
Dougherty JD, Garcia AD, Nakano I, Livingstone M, Norris B, Polakiewicz R et al. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. J Neurosci 2005; 25: 10773–10785.
Nandi AK, Rapoport AP . Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF. Leuk Res 2006; 30: 437–447.
Ayllon V, O'Connor R . PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene 2007; 26: 3451–3461.
Joel M, Mughal AA, Grieg Z, Murrell W, Palmero S, Mikkelsen B et al. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo. Mol Cancer 2015; 14: 121.
Zlobec I, Molinari F, Kovac M, Bihl MP, Altermatt HJ, Diebold J et al. Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. Br J Cancer 2010; 102: 151–161.
Shin J, Xie D, Zhong XP . MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase zeta. PLoS ONE 2013; 8: e77983.
He F, Yan Q, Fan L, Liu Y, Cui J, Wang J et al. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma. Hum Pathol 2010; 41: 415–424.
Lei B, Liu S, Qi W, Zhao Y, Li Y, Lin N et al. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression. Histopathology 2013; 63: 696–703.
Lei B, Qi W, Zhao Y, Li Y, Liu S, Xu X et al. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma. Hum Pathol 2015; 46: 217–224.
Acknowledgements
This work was supported by the Basic Science Research Program (no. 2014R1A2A1A11051988), Nuclear Research and Development Program (no. 2012-M2B2B1-2012055637), and Medical Research Center (MRC) (no. 201409392) through the National Research Foundation (NRF) funded by the Korean government (MSIP).
Author contributions
HCL and N-GH performed the majority of experiments and helped in writing the paper. DK and SHJ performed some experiments. JS, ML, and IHB coordinated the various collaborations and guided interpretation of the experimental data. Y-NK, HJP, and Y-GK developed ideas and provided critical discussion. J-SL conceived the study and wrote the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by G Calin
Supplementary Information accompanies this paper on Cell Death and Disease website
Supplementary information
Rights and permissions
Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Lee, H., Her, NG., Kang, D. et al. Radiation-inducible miR-770-5p sensitizes tumors to radiation through direct targeting of PDZ-binding kinase. Cell Death Dis 8, e2693 (2017). https://doi.org/10.1038/cddis.2017.116
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cddis.2017.116
This article is cited by
-
Role of non-coding RNAs in response of breast cancer to radiation therapy
Molecular Biology Reports (2022)
-
MicroRNA-153-5p promotes the proliferation and metastasis of renal cell carcinoma via direct targeting of AGO1
Cell Death & Disease (2021)
-
PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma
Cell Death & Disease (2019)
-
Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma
Journal of Neuro-Oncology (2019)
-
MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
Cell Death & Disease (2018)